LLU's shared-use facility to advance cellular therapy and regenerative medicine
Official title: BRF: LLU Cellular Therapy Research Facility
Funded at Loma Linda University · NIH-11523347 · Data updated 2026-11-12
A new shared laboratory facility at Loma Linda University will enable cell therapy and regenerative medicine work that could help people with cancer, blood disorders, and immune-related conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Loma Linda University NIH-funded |
| Lab location | 1 site (Loma Linda, UNITED STATES) |
| Project start | September 18, 2026 |
| Project end | January 1, 2028 |
| Funding year | 2026 |
| Award (this year) | $8,000,000 |
| NIH project number | 1C06OD042711-01 |
| Project ID | NIH-11523347 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with cancer or immune-mediated or genetic disorders who may be eligible for future CGRMT trials or treatments developed at LLU.
✕Less likely to help
This grant funds infrastructure; immediate patient benefits depend on future studies and therapies that use the facility.
What this research studies
This grant funds construction of a centralized facility that will house equipment and spaces for basic, translational, and clinical CGRMT research. Researchers will work on hematologic and solid cancers, sickle cell disease, neurodegenerative disorders, primary immune deficiencies, and other immune-mediated conditions using cell and gene therapies. The project emphasizes GMP-compliant infrastructure and collaboration to move therapies from the lab toward patient care. The facility aims to support LLU’s goal of becoming an NCI-designated Comprehensive Cancer Center and to expand access to advanced therapies in a regional population with high disease burden. The funding covers construction and operational setup over the grant period to enable future clinical translation and patient-oriented studies.
Why it matters
Potential benefit: Patients could benefit later from therapies developed in this advanced facility.
How similar studies have gone: Shared-use CGRMT facilities have accelerated translation in several centers, though each project’s clinical impact depends on subsequent trials.
Where this research is happening
-
Loma Linda University
Loma Linda, United States Active
Researchers
- Principal investigator: Losey, Travis Erik — Loma Linda University
- Study coordinator: Losey, Travis Erik
Related research
Other NIH-funded projects on the same topics.
-
Brain support cells in newborn brain injury after birth asphyxia
This grant studies how brain-supporting cells called pericytes affect brain damage after a newborn experiences a lack of oxygen at birth, with potential to guide new treatments.
-
Digitally supported community workers helping HPB cancer patients receive early palliative care
A pilot program uses digital tools and community health workers to bring early palliative care and support to people with HPB cancers and their caregivers.
-
REASON Score: an epigenetic and clinicopathologic approach to predict survival risk in early oral cancer
A new biomarker-based score using DNA methylation and clinicopathology to predict survival risk for people with early-stage oral squamous cell carcinoma.
-
Effects of chronic low oxygen on brain blood flow control in newborns
A study in newborns and animal models will explore how chronic low oxygen affects the brain’s ability to keep blood flow steady, which is crucial for preventing brain injuries.
-
Endothelial potassium channels and brain aging
A study in mice and aging adults to understand how tiny blood vessels in the brain fail and contribute to dementia, with the goal of identifying targets to protect brain blood flow in people at risk.
-
How low oxygen in pregnancy changes uterine blood flow
Researchers are learning how low oxygen during pregnancy changes uterine blood flow and how that can affect pregnant people and their babies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.